Tearlab Corp (TEAR) Financial Statements (2024 and earlier)
Company Profile
Business Address |
9980 HUENNEKENS ST. SAN DIEGO, CA 92121 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 7,108 | 9,354 | 9,173 | 8,860 | 8,473 | 8,240 | |||
Cash and cash equivalents | 7,108 | 9,354 | 9,173 | 8,860 | 8,473 | 8,240 | |||
Receivables | 917 | 978 | 1,123 | 1,098 | 1,186 | 1,319 | |||
Inventory, net of allowances, customer advances and progress billings | 2,269 | 2,902 | 2,832 | 2,207 | 1,987 | 1,752 | |||
Inventory | 2,269 | 2,902 | 2,832 | 2,207 | 1,987 | 1,752 | |||
Prepaid expense | 508 | 133 | 132 | 281 | 420 | 153 | |||
Other current assets | 2 | 1 | 2 | 1 | 1 | ||||
Other undisclosed current assets | 1,052 | 217 | 222 | 350 | 269 | 245 | |||
Total current assets: | 11,856 | 13,585 | 13,484 | 12,797 | 12,336 | 11,709 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 645 | 678 | 677 | 738 | ✕ | ✕ | |||
Property, plant and equipment | 1,670 | 1,534 | 1,626 | 1,797 | 2,024 | 1,894 | |||
Intangible assets, net (including goodwill) | 2 | 2 | 2 | 2 | 2 | 3 | |||
Intangible assets, net (excluding goodwill) | 2 | 2 | 2 | 2 | 2 | 3 | |||
Other noncurrent assets | 120 | 120 | 150 | 150 | 151 | 150 | |||
Total noncurrent assets: | 2,437 | 2,334 | 2,455 | 2,687 | 2,177 | 2,047 | |||
TOTAL ASSETS: | 14,293 | 15,919 | 15,939 | 15,484 | 14,513 | 13,756 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 2,935 | 3,759 | 3,509 | 3,239 | 3,044 | 3,182 | |||
Accounts payable | 599 | 1,423 | 1,425 | 1,319 | 681 | 1,053 | |||
Accrued liabilities | 2,336 | 2,336 | 2,084 | 1,920 | 2,363 | 2,129 | |||
Debt | 36,818 | 25,771 | 16,668 | 8,202 | 11,221 | ||||
Deferred rent credit | 2 | 3 | 4 | 7 | 13 | 17 | |||
Other undisclosed current liabilities | |||||||||
Total current liabilities: | 39,755 | 29,533 | 20,181 | 11,448 | 3,057 | 14,420 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 429 | 11,136 | 18,771 | 25,899 | 32,014 | 19,526 | |||
Long-term debt, excluding current maturities | 10,668 | 18,278 | 25,381 | 32,014 | 19,526 | ||||
Liabilities, other than long-term debt | 130 | 124 | 119 | 113 | 111 | ||||
Due to related parties | 130 | 124 | 119 | 113 | 111 | ||||
Operating lease, liability | 429 | 468 | 493 | 518 | ✕ | ✕ | |||
Total noncurrent liabilities: | 559 | 11,260 | 18,890 | 26,012 | 32,125 | 19,526 | |||
Total liabilities: | 40,314 | 40,793 | 39,071 | 37,460 | 35,182 | 33,946 | |||
Equity | |||||||||
Equity, attributable to parent | (26,021) | (24,874) | (23,132) | (21,976) | (20,669) | (20,190) | |||
Common stock | 13 | 13 | 12 | 12 | 11 | 11 | |||
Additional paid in capital | 510,442 | 510,436 | 510,429 | 510,411 | 510,380 | 510,346 | |||
Accumulated deficit | (536,476) | (535,323) | (533,573) | (532,399) | (531,060) | (530,547) | |||
Total equity: | (26,021) | (24,874) | (23,132) | (21,976) | (20,669) | (20,190) | |||
TOTAL LIABILITIES AND EQUITY: | 14,293 | 15,919 | 15,939 | 15,484 | 14,513 | 13,756 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 5,493 | 5,628 | 5,851 | 5,683 | 5,988 | 6,152 | ||
Cost of revenue (Cost of Goods and Services Sold) | (2,161) | |||||||
Other undisclosed gross profit | (2,023) | (2,089) | (2,162) | (2,083) | (2,330) | (222) | ||
Gross profit: | 3,470 | 3,539 | 3,689 | 3,600 | 3,658 | 3,769 | ||
Operating expenses | (3,132) | (3,841) | (3,457) | (3,593) | (2,909) | (2,771) | ||
Operating income (loss): | 338 | (302) | 232 | 7 | 749 | 998 | ||
Nonoperating expense | (1,490) | (1,448) | (1,406) | (1,346) | (1,261) | (1,193) | ||
Interest and debt expense | (1,493) | (1,455) | (1,007) | (994) | ||||
Other undisclosed income from continuing operations before equity method investments, income taxes | 5,703 | 3,793 | ||||||
Income (loss) from continuing operations before equity method investments, income taxes: | 3,058 | (3,205) | (1,174) | (2,346) | 2,287 | (195) | ||
Other undisclosed income from continuing operations before income taxes | 10,832 | 4,502 | ||||||
Income (loss) from continuing operations: | 13,890 | (3,205) | (1,174) | (2,346) | 6,789 | (195) | ||
Income (loss) before gain (loss) on sale of properties: | 13,890 | (3,205) | (1,174) | (2,346) | 6,789 | (195) | ||
Net income (loss): | 13,890 | (3,205) | (1,174) | (2,346) | 6,789 | (195) | ||
Other undisclosed net income (loss) attributable to parent | (15,042) | 1,455 | 1,007 | (7,301) | ||||
Net loss available to common stockholders, diluted: | (1,152) | (1,750) | (1,174) | (1,339) | (512) | (195) |
Comprehensive Income ($ in thousands)Annual | Quarterly
3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 13,890 | (3,205) | (1,174) | (2,346) | 6,789 | (195) | ||
Comprehensive income (loss), net of tax, attributable to parent: | 13,890 | (3,205) | (1,174) | (2,346) | 6,789 | (195) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.